Evolution and Influence of Insulin Marketing Strategies

The chapter delves into the history and impact of bioengineered insulin introduction in 1982, highlighting the marketing tactics that led to widespread adoption despite limited evidence of its superiority. It explores the evolution of insulin pricing, the push for tighter blood sugar control, and the influence of manufacturers on medical practices. The discussion also addresses the ethical concerns surrounding insulin pricing, lack of competition among manufacturers, and the need for government intervention to address market failures.